Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Por un escritor de hombre misterioso
Descripción
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Frontiers Plant Products as Inhibitors of Coronavirus 3CL Protease
Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine? - Nitin Sharma, Giriraj T. Kulkarni, Anant Narayan Bhatt, Saurabh Satija, Lubhan Singh, Anjana Sharma, Kamal Dua, Ritu Karwasra
Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Frontiers Plant in vitro Culture Technologies; A Promise Into Factories of Secondary Metabolites Against COVID-19
Viruses, Free Full-Text
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis
Small molecules in the treatment of COVID-19
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis
IJMS, Free Full-Text
Advances in natural product anti-coronavirus research (2002-2022), Chinese Medicine
Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro
Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective
de
por adulto (el precio varía según el tamaño del grupo)